Finally, MCL is characterized by aberrant activation of the BCR pathway, which is initiated by BCR stimulation and BTK activation to regulate the downstream NF-κB and PI3K/AKT/mTOR pathways. This evidence concerns the gene MTOR and mantle cell lymphoma.